FcRn inhibitors show promise for future of FNAIT treatment
New research suggests FcRn inhibitors may one day help prevent platelet destruction in conditions like immune thrombocytopenia and FNAIT.
New research suggests FcRn inhibitors may one day help prevent platelet destruction in conditions like immune thrombocytopenia and FNAIT.
New guidelines aim to standardize neonatal magnetic resonance imaging (MRI) practices, which currently vary widely across centers.
The study is the first to identify newborns simultaneously affected by rare blood disorders FNAIT and NAIN.
Researchers proposed a new framework that considers the “whole system” of transfusion exposure in newborn care.
Learn more about why testing a mother’s blood may not always be enough to detect FNAIT and what can be done to confirm a diagnosis.
Researchers identified forty different definitions and nearly thirty models of family-centered care in neonatal medicine across the globe.
Learn more about the risks and benefits of intrauterine platelet transfusions for both mothers and infants.
Learn more about intrauterine platelet transfusions, including their risks, benefits and what patients can expect during the procedure.
A highly sensitive genetic testing technology could make prenatal testing for conditions like FNAIT both safer and more accessible.
Learn more about what to expect during your first postpartum appointment after you bring your infant home from the hospital.